$156.48 $0.87 (0.6%)

04:00 PM EDT on 10/17/19

Insulet Corp (NASDAQ:PODD)

CAPS Rating: 4 out of 5

Dvlp,mftr,mkt insulin infusion system for diabetes

Current Price $156.48 Mkt Cap $9.4B
Open $156.89 P/E Ratio 0.00
Prev. Close $155.61 Div. (Yield) $0.76 (0.0%)
Daily Range $155.35 - $158.11 Volume 691,458
52-Wk Range $70.80 - $168.98 Avg. Daily Vol. 20

Caps

How do you think NASDAQ:PODD will perform against the market?

Add Stock to CAPS Watchlist

All Players

116 Outperform
41 Underperform
 

All-Star Players

42 Outperform
7 Underperform
 

Wall Street

16 Outperform
3 Underperform
 

Top NASDAQ:PODD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

BACnumber1 (< 20)
Submitted February 13, 2010

Watch Supersize Me. Once you watch the whole movie, you'll know why this stock is poised for greatness along with any other insulin provider

delos2 (< 20)
Submitted August 11, 2008

Not a market guy, but a manufacturing guy. Insulet was my account up until last year when the printed circuit board company I worked for finally gave up to offshore pressure. I knew a lot of these guys and I am amazed this company has not taken off… More

NASDAQ:PODD VS S&P 500 (SPY)

Fools bullish on NASDAQ:PODD are also bullish on:

Fools bearish on NASDAQ:PODD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PODD.

Recs

0
Member Avatar Reybe (< 20) Submitted: 9/25/2019 9:38:26 PM : Outperform Start Price: $164.17 NASDAQ:PODD Score: -5.19

Diabetes. Has a technical advantage.

Recs

0
Member Avatar TMFEBCapital (73.96) Submitted: 10/25/2018 10:14:02 AM : Outperform Start Price: $84.42 NASDAQ:PODD Score: +73.89

Demand for Insulet's wireless insulin pump, Omnipod, could slip short-term because of Tandem Diabetes automated insulin system, but I expect a similar system to become available from Insulet soon and if so, then its flexible design and loyal customer base could drive adoption in most type 1 patients, plus many insulin intensive type 2 patients (over time).

Recs

0
Member Avatar NHWeston102 (67.25) Submitted: 8/4/2016 11:33:38 AM : Outperform Start Price: $42.20 NASDAQ:PODD Score: +232.64

Moving into a take-off point with a simple semi-artificial pancreas device that will be highly competitive with Medtronics, JNJ, Tandem and others in this space. In the "Internet-of-Things", you, too, is a "thing."

Leaderboard

Find the members with the highest scoring picks in PODD.

Score Leader

SheepInvstr321

SheepInvstr321 (95.12) Score: +3,365.06

The Score Leader is the player with the highest score across all their picks in PODD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SheepInvstr321 95.12 4/15/2009 Outperform 5Y $4.20 +3,625.71% +257.44% +3,368.28 0 Comment
billwdude 96.36 11/17/2008 Outperform 5Y $4.29 +3,547.55% +255.27% +3,292.28 1 Comment
SSPX4 96.48 5/4/2009 Outperform NS $5.78 +2,607.27% +241.34% +2,365.93 0 Comment
UnderTenBucks 86.44 5/4/2009 Outperform NS $5.78 +2,607.27% +241.34% +2,365.93 0 Comment
rogbob1 97.05 5/26/2009 Outperform 5Y $6.62 +2,263.75% +242.06% +2,021.69 0 Comment
SSPX911 96.90 5/14/2009 Outperform NS $6.75 +2,218.22% +240.67% +1,977.56 0 Comment
MaximumDamage 80.43 5/18/2009 Outperform NS $6.85 +2,184.38% +237.51% +1,946.87 0 Comment
SSPX8 72.56 6/8/2009 Outperform 5Y $7.34 +2,031.88% +222.08% +1,809.80 0 Comment
SSPX0 74.69 6/8/2009 Outperform 5Y $7.34 +2,031.88% +222.08% +1,809.80 0 Comment
freedomfrys 40.56 6/5/2009 Outperform 5Y $7.45 +2,000.40% +221.28% +1,779.12 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJPMorgan 86.91 8/6/2019 Outperform NS $117.93 +32.69% +4.62% +28.07 0 Comment
TrackRWBaird 89.58 1/6/2017 Outperform NS $38.12 +310.49% +32.05% +278.44 0 Comment
TrackTheBenchmar 80.01 10/15/2013 Outperform NS $36.22 +332.03% +75.43% +256.59 0 Comment
TrackUltraLong < 20 8/6/2012 Underperform NS $19.64 +696.74% +114.09% -582.65 1 Comment
TrackRSGoodFCF < 20 4/19/2012 Outperform 5Y $17.47 +795.71% +117.20% +678.51 0 Comment
TrackPoisedTo < 20 4/3/2012 Underperform 5Y $19.21 +714.58% +111.19% -603.39 0 Comment
TrackRSGoodFCF < 20 1/25/2012 Outperform 5Y $19.66 +0.51% +2.70% -2.20 2/22/2012 @ $19.76 0 Comment
TrackBreanMurray 20.12 1/17/2012 Outperform NS $19.65 +696.34% +129.96% +566.38 0 Comment
TrackFeltlandCo 88.35 9/30/2011 Outperform NS $15.72 +895.42% +161.36% +734.06 0 Comment
TrackWunderlich < 20 9/23/2011 Outperform NS $14.99 +102.40% +45.87% +56.54 6/7/2013 @ $30.34 0 Comment
TrackRodmanRen < 20 7/25/2011 Underperform NS $21.44 +629.85% +124.40% -505.45 0 Comment
TrackOppenheimer < 20 5/18/2011 Outperform NS $20.63 +658.51% +124.50% +534.00 0 Comment
TrackJimCramer 86.29 3/18/2011 Outperform 3W $18.28 +756.02% +134.13% +621.88 0 Comment
TrackJefferies 75.59 12/3/2010 Outperform NS $13.92 +1,024.14% +144.91% +879.23 0 Comment
TrackJMP 84.43 9/15/2010 Outperform NS $13.95 +1,021.72% +165.42% +856.30 0 Comment
TrackBarrington 84.74 5/7/2010 Outperform NS $14.49 +979.92% +165.56% +814.35 0 Comment
TrackWMBlair 73.84 10/27/2009 Outperform NS $9.70 +1,513.20% +179.48% +1,333.71 0 Comment
TrackSoleil 92.63 9/10/2009 Outperform NS $9.88 +1,483.81% +189.56% +1,294.24 0 Comment
TrackCanaccord 51.19 1/8/2009 Outperform NS $9.00 +1,638.67% +237.64% +1,401.03 0 Comment
TrackSMHCapital 36.80 7/29/2008 Outperform NS $13.00 +1,103.69% +146.58% +957.12 0 Comment
TrackJMP 84.43 5/12/2008 Outperform NS $19.06 -81.64% -49.61% -32.03 3/6/2009 @ $3.50 0 Comment
TrackBarrington 84.74 4/24/2008 Outperform NS $18.11 -80.67% -48.98% -31.69 3/6/2009 @ $3.50 0 Comment
TrackHSBC 28.98 10/11/2007 Outperform NS $25.21 +520.83% +99.14% +421.69 0 Comment
TrackWMBlair 73.84 10/2/2007 Outperform NS $22.60 -77.39% -40.82% -36.57 11/7/2008 @ $5.11 0 Comment
TrackCanaccord 51.19 9/10/2007 Outperform NS $17.93 -11.27% -9.01% -2.25 6/20/2008 @ $15.91 0 Comment
TrackBWS 96.15 9/4/2007 Outperform NS $17.61 -80.12% -52.41% -27.71 3/6/2009 @ $3.50 0 Comment